Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hercules Capital, Inc. Common Stock (NY:HTGC)

17.28 -0.29 (-1.65%)
Streaming Delayed Price Updated: 11:45 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hercules Capital, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Reflecting On Specialty Finance Stocks’ Q3 Earnings: Hercules Capital (NYSE:HTGC)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the specialty finance industry, including Hercules Capital (NYSE:HTGC) and its peers. 
Via StockStory
News headline image
5 Insightful Analyst Questions From Hercules Capital’s Q3 Earnings Call
Hercules Capital’s third quarter was shaped by robust originations and disciplined credit underwriting, which management identified as key drivers of performance. CEO Scott Bluestein highlighted record... 
Via StockStory
Topics Earnings
News headline image
This Waste Management Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 1, 2025 ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Hercules Capital ↗
 
Via Benzinga
News headline image
HTGC Q3 Deep Dive: Disciplined Lending Drives Portfolio Growth Amid Mixed Market Conditions
Specialty finance company Hercules Capital (NYSE:HTGC) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.3% year on year to $138.1 million. Its GAAP profit of $0.63 per share was... 
Via StockStory
News headline image
Hercules Capital Inc (NYSE:HTGC) Reports Mixed Q3 2025 Results, Misses EPS Estimates ↗
Hercules Capital (HTGC) reports Q3 2025 results with a revenue beat but an earnings per share miss, leading to a negative after-hours stock reaction. 
Via Chartmill
News headline image
Exploring Hercules Capital's Earnings Expectations ↗
 
Via Benzinga
News headline image
Hercules Capital (HTGC) Q3 Earnings: What To Expect
Specialty finance company Hercules Capital (NYSE:HTGC) will be reporting earnings this Thursday afternoon. Here’s what investors should know. 
Via StockStory
News headline image
Muzinich Bets Heavily on Hercules Capital (HTGC) by Acquiring 254,651 Shares ↗
Muzinich Bets Heavily on Hercules Capital (HTGC) by Acquiring 254,651 Shares 
Via The Motley Fool
News headline image
Kimberly-Clark Stock Shows Its Strength as Defensive Names Come Back in Focus ↗
Kimberly-Clark Stock Shows Its Strength as Defensive Names Come Back in Focus 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Gilman Hill Adds $7.9 Million Millrose Stake — Bolstering Dividend Income Strategy ↗
Via The Motley Fool
News headline image
Fund Buys $7.9 Million in NextEra Energy Stock as Clean Power Growth, Yield Attract Investors ↗
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Investment Manager Rebalances, Trims Stake in Hercules Capital ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Big Money Moves: $4.1 Million of Oracle Shares Dumped by Investment Advisor ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Value Stocks with Open Questions
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
News headline image
Why Hercules Capital (HTGC) Shares Are Sliding Today
Shares of specialty finance company Hercules Capital (NYSE:HTGC) fell 2.8% in the afternoon session after analyst firm Piper Sandler lowered its price target on the stock. Analyst Crispin Love reduced... 
Via StockStory
Topics Artificial Intelligence
News headline image
Q2 Earnings Highs And Lows: Hercules Capital (NYSE:HTGC) Vs The Rest Of The Specialty Finance Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at specialty finance stocks, starting with... 
Via StockStory
News headline image
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial ↗
UniQure's AMT-130 gene therapy slowed Huntington's disease progression in a Phase 1/2 trial, supported by new $175 million financing for launch readiness. 
Via Benzinga
News headline image
2 Safe-and-Steady Stocks to Target This Week and 1 We Brush Off
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
3 Small-Cap Stocks We Steer Clear Of
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
1 Financials Stock with Promising Prospects and 2 We Ignore
Financial firms serve as the backbone of the economy, providing essential services from lending and investment management to risk management and payment processing. But uncertainty about fiscal and... 
Via StockStory
Topics Credit Cards Economy Stocks
News headline image
Recent Report Shows That Rep. Virginia Foxx Sold Up to $65K Worth of Energy Transfer Stock ↗
 
Via Benzinga
News headline image
Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report ↗
Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from Keytruda's looming patent cliff. 
Via Benzinga
Topics Intellectual Property
News headline image
50-Year-Old Investor Craves 8%+ Yield, Snubs Ford, Chases Durable Dividends – 'I Am Willing To Consider Anything' For Monthly Income ↗
In today's unpredictable market, investors seeking high yields need to balance risk and reward carefully. With rising volatility, inflation concerns, and fluctuating interest rates, a well-diversified... 
Via Benzinga
Topics Economy
News headline image
What Analysts Are Saying About Hercules Capital Stock ↗
 
Via Benzinga
News headline image
Retired At 58, He 'Spent Between $1M-$2M On Stocks' – Investor Who Built An 8% Yield Portfolio And Lives Off Dividends Shares Top Holdings ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.